F.D.A. Expands Access to Clozapine, a Key Treatment for Schizophrenia
Federal regulators will no longer require patients to provide blood tests before receiving the drug from pharmacies.
Leader of FDA food division resigns
Jim Jones, head of the FDA's food division, has resigned. The division is tasked with ensuring the safety of the U.S. food ...
Modern Healthcare7d
Federal funding disruptions roil health system-led research
Grant funding uncertainty has jeopardized the sustainability of research projects and discouraged researchers.
KJZZ7d
How an FDA authorization hearing on MDMA led this New York Times reporter to shadowy organization
Last year, the path to FDA authorization of the psychedelic drug MDMA for treatment of PTSD hit an unexpected snag. It later ...
Produce Blue Book7d
FDA deputy commissioner for human foods resigns
Jim Jones, deputy commissioner for human foods at the U.S. Food and Drug Administration (FDA), resigned yesterday.
HUB7d
NIH-funded research revolutionizes treatment of age-related hearing loss
After NIH-funded studies linked untreated hearing loss to health issues such as dementia, Hopkins professor Frank Lin ...
EurekAlert!1d
Researchers identify new p53 targets to combat cancer growth
A new research paper was published in Oncotarget, Volume 16, on February 18, 2025, titled “Robust p53 phenotypes and ...
phillyvoice.com13d
Fibromyalgia leaves people with widespread muscle pain – but its cause remains unknown
About 4 million American adults have the chronic condition. Treatment may include a combination of painkillers, cognitive ...
Armed robbery in Revesby1d
Neuren Gets FDA Rare Pediatric Disease Status
Neuren Pharmaceuticals (ASX:NEU) has received a Rare Paediatric Disease Designation from the US FDA for NNZ-2591 in ...
JD Supra5d
New Administration Outlook: Four Food Industry Insights, From RFK to FDA and SNAP to Tariffs
With the confirmation of Robert F. Kennedy Jr. as secretary of Health and Human Services, as well as Brooke Rollins as secretary of the Department ...
News Medical on MSN1d
Study finds key p53 targets for future cancer treatment
A new research paper was published in , Volume 16, on February 18, 2025, titled "Robust p53 phenotypes and prospective downstream targets in telomerase-immortalized human cells." ...